Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Asset disposition
Class action filed
|
|
Cellectar Biosciences, Inc. (CLRB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/25/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/08/2021 |
SC 13G
| Rosalind Advisors, Inc. reports a 6% stake in Cellectar Biosciences, Inc. |
| 02/17/2021 |
SC 13G
| Consonance Capital Management LP reports a 10% stake in CELLECTAR BIOSCIENCES INC |
| 02/16/2021 |
SC 13G
| Consonance Capital Management LP reports a 10% stake in CELLECTAR BIOSCIENCES INC |
| 02/16/2021 |
SC 13G
| Sio Capital Management, LLC reports a 8.7% stake in Cellectar Biosciences, Inc. |
| 07/13/2020 |
SC 13G
| Lincoln Park Capital Fund, LLC reports a 8.9% stake in CELLECTAR BIOSCIENCES, INC. |
| 06/12/2020 |
SC 13G
| ARMISTICE CAPITAL, LLC reports a 5% stake in Cellectar Biosciences, Inc. |
| 06/12/2020 |
SC 13G
| LYTTON LAURENCE W reports a 10% stake in Cellectar Biosciences, Inc. |
| 06/10/2020 |
SC 13G
| HIRSCHMAN ORIN reports a 6.5% stake in Cellectar Biosciences, Inc. |
| 06/28/2019 |
SC 13G
| North Sound Trading, LP reports a 9% stake in Cellectar Biosciences, Inc. |
| 05/28/2019 |
SC 13G
| Boxer Capital, LLC reports a 10% stake in Cellectar Biosciences Inc. |
| 05/28/2019 |
SC 13G
| TANG CAPITAL PARTNERS LP reports a 6.8% stake in Cellectar Biosciences, Inc. |
| 05/28/2019 |
SC 13G
| Anson Funds Management LP reports a 6.4% stake in Cellectar Biosciences, Inc. |
| 05/24/2019 |
SC 13G
| INTRACOASTAL CAPITAL, LLC reports a 6.1% stake in Cellectar Biosciences, Inc. |
| 02/15/2019 |
SC 13G
| UBS Group AG reports a 6.8% stake in Cellectar Biosciences Inc |
| 06/02/2016 |
SC 13G
| Hertzberg Richard has filed a Schedule 13D for CELLECTAR BIOSCIENCES INC |
| 03/14/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 02/14/2011 |
SC 13G
| NOVELOS THERAPEUTICS, INC. reports a 8.6% stake in NOVELOS THERAPEUTICS, INC. |
| 12/10/2010 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
|
|